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Abstract Cartilage matrix is stabilised by the interactions of
proteins with hyaluronan (HA). We compare the pH dependences
of HA binding by aggrecan, link protein and TSG-6. Aggrecan
and link protein exhibit maximal binding across a wide pH range
(6.0^8.0). TSG-6, a protein that is only produced during
inflammation, binds maximally at about pH 6.0 but shows a
dramatic loss of function with increasing pH. TSG-6 also
interacts with aggrecan, with a similar pH dependence, and this
can be inhibited by HA. Thus, a common binding surface on
TSG-6 may be involved in HA and aggrecan binding. We
propose that TSG-6 is involved in matrix dissociation and that
this is regulated by pH gradients in cartilage.
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1. Introduction
Hyaluronan (HA) is a glycosaminoglycan (GAG), of very
high molecular weight (105^107 Da), comprised of the repeat-
ing disaccharide, D-glucuronic acid (L1C3) N-acetyl-D-glucos-
amine (L1C4). It is found in all organs and body £uids of
adult vertebrates, particularly in connective tissues (e.g. syno-
vial £uid, skin and cartilage), and is especially abundant dur-
ing development and morphogenesis [1]. HA has a central role
in the formation and stability of extracellular matrix by its
interactions with HA-binding proteins and receptors [2].
These interactions are usually mediated by a common protein
domain (of approximately 100 amino acids in length), termed
a Link module or proteoglycan tandem repeat (see [3]). In
cartilage three members of the Link module superfamily,
Link protein (Lp), aggrecan and CD44, have been particularly
well characterised. The roles of these molecules, and the re-
cently discovered cartilage protein TSG-6 (the product of tu-
mour necrosis factor (TNF)-stimulated gene-6), are reviewed
in brief below.
The interaction of the proteoglycan aggrecan with HA is
mediated by its N-terminal G1 domain [4,5] which is com-
prised of an immunoglobulin module followed by two contig-
uous Link modules. The same organisation of modules is
found in Lp, where the Link modules are both involved in
binding to HA and the immunoglobulin module mediates the
interaction with G1 [6]. Electron microscopy has revealed that
a dense array of alternating aggrecan and Lp molecules forms
along a central hyaluronan ¢lament [7]. These huge multimo-
lecular structures can contain over 100 molecules of both Lp
and aggrecan associated with a single HA chain, and give rise
to aggregates with molecular masses of 108^109 Da (see [8]).
These aggregates are hydrated, due to their high ¢xed negative
charge resulting from the very large numbers of sulphated
GAG chains on aggrecan, and constitute a space-¢lling gel
that provides cartilage with its load bearing properties.
The major HA receptor CD44 contains a single Link mod-
ule that is involved in HA binding [9,10]. In cartilage CD44
has an important role in the assembly and organisation of
chondrocyte pericellular matrix by mediating the attachment
of HA-proteoglycan aggregates to the cell surface [11].
TSG-6 contains a single Link module [12] that has been
shown to interact speci¢cally with HA [3,13]. There is little
or no constitutive expression of TSG-6 mRNA in chondro-
cytes in vitro, but rapid transcription and subsequent secre-
tion of the gene product is seen after treatment with interleu-
kin-1 (IL-1) or TNF [14,15]. TSG-6 protein has been found at
high levels in the synovial £uids of patients with various forms
of arthritis, including rheumatoid (RA) and osteoarthritis
(OA), but was not detected in synovial £uids from individuals
without known joint disease [16]. Immunolocalisation studies
have shown that there is no detectable TSG-6 in normal hu-
man articular cartilage, while in OA and RA there is signi¢-
cant staining of the chondrocytes and their associated pericel-
lular matrices, especially in the deep layer of the tissue (S.L.T.
Howat, A.J. Day and M.T. Bayliss, unpublished data). There-
fore, it seems likely that TSG-6 is produced in cartilage during
in£ammation. IL-1 and TNF are well known to have a central
role in the induction of cartilage breakdown in arthritis (see
[17]), which suggests that TSG-6 may be involved in these
processes [12,16]. In apparent contradiction to this hypothesis
TSG-6 has been shown to potentiate the inhibition of plasmin
(which has an important role in the activation of latent metal-
loproteinases involved in extracellular matrix degradation; see
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[18]) by inter-K inhibitor (IKI), with which TSG-6 forms a
covalent complex [19].
Recently we have expressed the Link module from TSG-6
(denoted Link_TSG6) in E. coli [20,21] and this has been used
to determine its tertiary structure by nuclear magnetic reso-
nance (NMR) spectroscopy [3]. In addition, we have demon-
strated that Link_TSG6 interacts with HA using microtitre
plate assays [3,13]. Here we show that the pH dependence
of HA binding by Link_TSG6 is strikingly di¡erent to that
of Lp and the G1 domain of aggrecan (G1). Aggrecan is
identi¢ed as a novel ligand for TSG-6 and the pH dependence
of this interaction is shown to be very similar to that of HA
binding to Link_TSG6. Our results have important implica-
tions for cartilage where di¡erent pH environments may mod-
ulate alternative functions of TSG-6.
2. Materials and methods
2.1. Materials
Microtitre plates, development reagents, human umbilical cord HA
(mean molecular weight 4.4U106 Da), 250 kDa biotinylated HA
(bHA), the Link module from human TSG-6 (denoted Link_TSG6)
and mono-biotinylated Link_TSG6 (bA-Link_TSG6) used in the
binding assays were as described previously [3,13]. Lp, G1 and bio-
tinylated G1 (b-G1) were prepared from porcine laryngeal cartilage as
described before [4,22]; Lp was stored in 4 M guanidine-HCl, 50 mM
Na-acetate, 1 mM Na2-EDTA, pH 5.8, due to its low solubility in
water. Both G1 and b-G1, following biotinylation in the presence of
HA, were puri¢ed by gel ¢ltration under dissociative conditions (i.e.
to remove HA) [4,22]. These preparations re-chromatographed as
monomers under associative conditions and were shown to be free
from contaminating HA by the assay of Fosang et al. [22] after di-
gestion of protein with papain. Recombinant protein domains from
human ¢bronectin (1F1-2F1 and 4F1-5F1) used as binding assay con-
trols were kindly provided by Dr Jennifer Potts (Department of Bio-
chemistry, University of Oxford).
2.2. Plate binding assays
Microtitre plate binding assays were carried out to investigate the
e¡ect of pH on the interactions of HA with Link_TSG6, G1 and Lp;
and whether Link_TSG6 interacts directly with G1. The assays, which
are based on those described previously [3,13], all determine colori-
metrically the level of binding of biotinylated ligand (i.e. bHA, bA-
Link_TSG6 or b-G1) to wells coated with either HA or protein.
2.2.1. Standard assay. All dilutions, incubations and washes were
performed in standard assay bu¡er (SAB: 50 mM Na-acetate, 100
mM NaCl, 0.05% (v/v) Tween 20 pH 5.8) at room temperature unless
otherwise stated. Plastic Linbro microtitre plates (EIA II Plus) were
coated overnight with 200 Wl/well of protein, or HA, in 20 mM
Na2CO3 pH 9.6. Control wells were treated with bu¡er alone. The
coating solution was removed and the plates were washed three times
with SAB. Non-speci¢c binding sites were blocked by incubation with
1% (w/v) bovine serum albumin for 90 min at 37‡C, followed by three
washes. Biotinylated ligand (200 Wl) was added to each well and in-
cubated for 4 h or overnight. Plates were washed three times and 200
Wl of a 1 in 10 000 dilution of Extra-Avidin alkaline phosphatase (in
SAB) was added and incubated for 30 min, followed by three washes.
A 1 mg/ml solution (200 Wl/well) of disodium p-nitrophenyl-phos-
phate, in 100 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl2, pH 9.3,
was added to all wells and incubated until su⁄cient colour had de-
veloped. The absorbance at 405 nm was determined on a microtitre
plate reader (MKII Titertek Multiscan Plus). All absorbances were
corrected against blank wells and were then standardised to a 10 min
development time.
2.2.2. pH dependence of hyaluronan interactions. The e¡ect of pH
on the interaction of bHA with plates coated with Link_TSG6 (22
pmol/well), G1 (18 pmol/well) or Lp (2.5 pmol/well) was investigated
using a modi¢cation of the above assay. Plates were coated, blocked
and washed as described for the standard assay. Following this, fur-
ther dilutions, incubations and washes were performed in 100 mM
NaCl, 0.05% (v/v) Tween 20, bu¡ered to a speci¢c pH: 50 mM Na-
acetate was used from pH 3.5 to 6.5 and 50 mM Na-HEPES (N-[2-
hydroxyethyl]piperazine-NP-[2-ethanesulfonic acid]) between pH 6.0
and 8.0. The pH values of all bu¡ers (for washing) and bHA solutions
were individually checked and adjusted if necessary. Wells were re-
washed, incubated with 12.5 ng (33 pmol DSequiv)2 bHA and washed
three times in bu¡er of the appropriate pH. The amount of bHA
binding was determined as described above for the standard assay.
This assay was repeated at pH 5.8 (Na-acetate bu¡er) and pH 7.4
(Na-HEPES bu¡er) on plates coated with 25 pmol of Link_TSG6,
G1, Lp, 1F1-2F1 or 4F1-5F1 per well.
The e¡ect of pH on the binding of bA-Link_TSG6 to HA was also
investigated. Plates were coated with 5 Wg/well (13.3 nmol DSequiv)
HA, blocked and washed as described for the standard assay. Wells
were then re-washed, incubated with 2 pmol bA-Link_TSG6 and
washed three times in the appropriate pH bu¡er as above, except
that in this assay 0.2% (v/v) Tween 20 was used. An increased con-
centration of detergent was necessary to avoid precipitation of bA-
Link_TSG6 at certain pH values. Plates were developed as before.
2.2.3. Binding of G1 to Link_TSG6. The possibility that TSG-6
could interact directly with G1 was initially investigated at pH 5.8.
The binding of b-G1 (1.5 pmol/well) to plates coated with 25 pmol/
well of Link_TSG6, 1F1-2F1 or 4F1-5F1 was determined under stand-
ard assay conditions. In addition the binding of bA-Link_TSG6 (2
pmol/well) to plates coated with 25 pmol/well of G1, 1F1-2F1 or 4F1-
5F1 was also determined under these conditions.
The binding of b-G1 to Link_TSG6 (coated at 22 pmol/well, as
described above) was then determined for a range of pH values
(3.5^8.0); further dilutions, incubations (with 1.5 pmol b-G1 per
well) and washes were performed in 100 mM NaCl, 0.2% (v/v) Tween
20, bu¡ered to a speci¢c pH (with either 50 mM Na-acetate pH 3.5^
6.5 or 50 mM Na-HEPES pH 6.0^8.0) as described in Section 2.2.2.
Plates were then treated as for the standard assay.
The speci¢city of G1-aggrecan binding to Link_TSG6 coated plates
(22 pmol/well) was investigated at pH 5.8 (in SAB with 0.2% (v/v)
Tween 20) by incubating 1.5 pmol b-G1 (per well) in the absence or
presence of unlabelled G1 (0.1^200 pmol/well) or HA (0.125^250 nmol
DSequiv/well).
2.3. One-dimensional NMR spectroscopy
About 10 mg of lyophilised Link_TSG6 were resuspended in 600 Wl
10% (v/v) D20, 0.02% (w/v) NaN3 resulting in an V1.5 mM protein
solution. The pH was carefully adjusted to the desired value (pH 3.5
to 8.5 in intervals of 0.5) by the addition of 1 M or 0.1 M NaOH.
After each pH adjustment any precipitated protein was removed by
centrifugation and a one-dimensional (1-D) NMR spectrum was re-
corded at 35‡C on a 500 MHz home-built/GE Omega spectrometer;
the residual solvent signal was suppressed by presaturation. The
NMR data were processed using FELIX 2.3 (Biosym Inc.), applying
deconvolution and a sinesquare window function for resolution en-
hancement. Proton chemical shifts were referenced to the H2O signal
at 4.7 ppm.
3. Results
3.1. The pH dependence of HA binding to TSG-6 compared
to aggrecan and Lp
Recently we have shown by microtitre plate assays that the
recombinant Link module of human TSG-6 (Link_TSG6) in-
teracts speci¢cally with HA [3,13]. Here we investigate the
e¡ect of pH on this interaction and compare it with that of
aggrecan and Lp with HA. Fig. 1a,b shows the e¡ects of pH
on bHA binding to G1 and Lp coated plates; giving similar
shaped curves, with minimal bHA binding at pH 3.5 and close
to maximal binding across the range pH 6.0^8.0. These results
are consistent with those for HA binding to G1 and Lp de-
termined previously by viscosity measurements [23,24] and
analytical ultracentrifugation [25], respectively. In the case
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of Link_TSG6 (Fig. 1c) there is also minimal binding at pH
3.5 which increases to a maximum at about pH 5.5. However,
unlike G1 and Lp, increasing the pH from 6.0 to 8.0 causes a
reduction in the binding of bHA to Link_TSG6 to almost
zero. In order to investigate whether this loss of binding ac-
tivity was an artefact of the Link_TSG6 being immobilised on
the microtitre plate, an assay was performed with protein (bA-
Link_TSG6) in solution binding to an HA coated plate. From
Fig. 1d it can be seen that the overall shape of the binding
curve is very similar to that in Fig. 1c with loss of Link_TSG6
function as the pH is increased from 6.0 to 8.0. This demon-
strates that HA binding is similarly e¡ected by pH whether
Link_TSG6 is immobilised or in solution.
It should be noted that for Lp (Fig. 1b) the level of bHA
binding was somewhat lower (about 30%) in the Na-HEPES
bu¡er system than in Na-acetate and for bA-Link_TSG6
binding to HA (Fig. 1d) this was approximately two times
greater in Na-HEPES than in Na-acetate. The cause of these
bu¡er e¡ects has not been investigated further.
To test the speci¢city of the bHA binding assay, microtitre
plates were coated with 25 pmol per well of G1, Lp,
Link_TSG6, or fragments of human ¢bronectin (1F1-2F1,
4F1-5F1) for which there is no evidence of HA binding. These
‘module pairs’ from ¢bronectin were chosen as controls as
they were produced by recombinant expression and are both
of similar size to Link_TSG6 (i.e. V10 kDa). Fig. 2 shows
that the results of this assay are consistent with those in Fig.
1: there is a similar level of binding of bHA to Lp and G1 at
both pH 5.8 and 7.4, but greatly decreased binding to
Link_TSG6 at pH 7.4 compared to pH 5.8. There was negli-
gible bHA binding to the control proteins under both pH
conditions. In addition, the binding of bHA to G1, Lp and
Link_TSG6 at pH 5.8 could be fully competed with unlabelled
HA (data not shown).
3.2. There is no gross structural change in Link_TSG6 between
pH 6 and 8
We have recently determined the tertiary structure of
Link_TSG6 by NMR spectroscopy in solution at pH 6.0 [3].
The Link module has a compact fold, comprised of two K-
helices and two triple-stranded antiparallel L-sheets arranged
around a large hydrophobic core which gives rise to a char-
acteristic 1-D NMR spectrum; with methyl resonances from
Val-57 shifted to high ¢eld (30.5 and 31.1 ppm) by their
close proximity to Trp-51 and Trp-88 in the core. The chem-
ical shifts of these methyl protons are very sensitive to struc-
tural change and can be used to monitor the e¡ect of pH on
the Link_TSG6 structure. Therefore, a series of 1-D spectra
were collected at a range of pH values as shown in Fig. 3. The
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Fig. 2. The binding of biotinylated-hyaluronan (bHA), at pH 5.8 or
7.4, to plates coated with 25 pmol G1, Lp, Link_TSG6, 1F1-2F1
and 4F1-5F1. Values are plotted as mean absorbance (n = 4) at
405 nm after 10 min development time þ S.E.M.
Fig. 1. The pH dependences of HA binding to G1, Lp and
Link_TSG6. The binding of bHA to wells coated with G1 (a), Lp
(b) or Link_TSG6 (c), and bA-Link_TSG6 binding to wells coated
with HA (d), were measured colorimetrically. Values are plotted as
mean absorbance (n = 3), at 405 nm after 10 min development
time þ S.E.M. The assays were performed over a range of pH values
in two di¡erent bu¡er systems (Na-acetate, solid lines; Na-HEPES,
dotted lines). In (d) absorbance values (from each of the bu¡ers)
are plotted on separate axes.
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spectrum at pH 6.0 is that of the folded module with the high
¢eld shifted methyl resonances mentioned above (shown by
arrows) and well-dispersed signals in the amide region (V7.5^
9.5 ppm). At pH 3.5, however, the spectrum is ‘collapsed’ (i.e.
with proton resonances at their random coil positions) with
no visible signals at 30.5 or 31.1 ppm indicating that
Link_TSG6 is unfolded. It is not surprising, therefore, that
Link_TSG6 does not interact with HA at this pH (see Fig.
1c,d). As the pH is increased from 3.5 to 6.0, high ¢eld shifted
methyls appear and increase in intensity. This demonstrates
that on raising the pH there is an increasing proportion of
folded protein present in the sample, that correlates with the
level of Link_TSG6 binding to HA over this pH range. How-
ever, as the pH is increased from 6.0 to 8.5 there are no
signi¢cant changes in the 1-D spectra (see Fig. 3) which in-
dicates that Link_TSG6 remains fully folded under these pH
conditions. Therefore, it can be concluded that the reduction
in HA binding by Link_TSG6 between pH 6.0 and 8.0 is not
due to a gross structural change in the Link module structure
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Fig. 4. The speci¢city and pH dependence of G1 binding to
Link_TSG6. a: The level of binding of b-G1 (black bars) or bA-
Link_TSG6 (white bars) to plates coated with 25 pmol/well of 1F1-
2F1 and 4F1-5F1 and either Link_TSG6 or G1-aggrecan, respec-
tively. b-d: The binding of b-G1 to plates coated with 22 pmol
Link_TSG6 was determined: at a range of pHs in two bu¡er sys-
tems (Na-acetate, solid line; Na-HEPES, dotted line) (b); and in
the absence (*) or presence of competing concentrations of unla-
belled G1 (c) or HA (d). Data points are plotted as mean values
(n = 3) þ S.E.M.
Fig. 3. One-dimensional NMR spectra of Link_TSG6 acquired at
di¡erent pH values (3.5^8.5). Proton chemical shifts were referenced
to H2O at 4.7 ppm. The position of the high-¢eld shifted methyl
protons from Val-57 are indicated by arrows. The additional reso-
nances seen between 2.5 and 3.0 ppm in the spectra at pH 7.0 and
above are due to a citrate bu¡er impurity arising from the pH me-
ter.
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and is likely to be due to a local change in a functional
element.
3.3. G1 interacts speci¢cally with Link_TSG6
The possibility that TSG-6 could interact with aggrecan was
investigated. Initially the binding of b-G1 to Link_TSG6 at
pH 5.8 was compared with control proteins (1F1-2F1 or 4F1-
5F1) coated on microtitre plates at 25 pmol/well. The results
of this assay are shown in Fig. 4a where it can be seen that
b-G1 does interact with Link_TSG6 but does not bind to the
control proteins. Fig. 4a also shows that bA-Link_TSG6
binds to a G1-coated plate (25 pmol/well) with only 9.7%
and 12.2% binding to wells with the same concentrations of
1F1-2F1 and 4F1-5F1, respectively. As no HA is detectable in
the G1 preparations (which were puri¢ed under dissociative
conditions; see Section 2.1) it is very unlikely that the inter-
action of Link_TSG6 with G1 results from HA contamina-
tion.
The e¡ect of pH on the interaction of b-G1 with immobi-
lised Link_TSG6 was investigated. As shown in Fig. 4b there
is minimal binding at pH 3.5, maximum binding between pH
5.5 and 6.0 and almost complete loss of binding on increasing
the pH to 8.0. The speci¢city of this interaction at pH 5.8
(maximal binding) was determined by binding b-G1 to plates
coated with Link_TSG6 in the absence or presence of unla-
belled G1. As can be seen from Fig. 4c b-G1 binding can be
competed by G1, with an IC50 value of V1.5 pmol (i.e. the
amount of b-G1 present in this assay), which indicates that
this interaction is speci¢c. In addition b-G1 binding to
Link_TSG6 can be inhibited by unlabelled HA (Fig. 4d), al-
beit at higher concentrations than with G1 (IC50W330 pmol
DSequiv). This suggests that either the HA and G1 binding
sites on Link_TSG6 overlap or that the HA and Link_TSG6
binding sites on G1 overlap. The former is the more likely as
the pH dependences of the interactions of Link_TSG6 with
G1 and HA are strikingly similar (see Figs. 1c,d and 4b).
Therefore, a common pH-sensitive functional element on the
TSG-6 Link module may be involved in both HA and aggre-
can binding.
4. Discussion
Here we have shown that the e¡ect of pH on HA binding
by the TSG-6 Link module is di¡erent from those of aggrecan
and link protein; with a dramatic reduction in HA binding
seen between pH 6.0 and 8.0. In addition, we have demon-
strated that Link_TSG6 interacts with the aggrecan G1 do-
main and that this is in£uenced by pH in a similar manner.
This loss of ligand binding is not due to a gross structural
change in Link_TSG6 and, therefore, may be of functional
relevance. We discuss below how such pH-dependent ligand-
binding may relate to the regulation of TSG-6 functional ac-
tivity in cartilage.
Cartilage is an avascular tissue with less than 5% of its
volume made up of cells (chondrocytes) ; the rest being com-
posed of extracellular matrix comprised of collagen ¢brils and
proteoglycan aggregates [8]. In this tissue there is a relatively
low O2 tension (as low as 1%) and as a consequence of this up
to 95% of chondrocyte glucose metabolism occurs by anaero-
bic glycolysis, leading to a signi¢cant production of lactic acid
(see [26,27]). The removal of lactic acid from cartilage relies
solely on di¡usion through the matrix, resulting in an acid-
i¢cation of the tissue with the lowest pH values likely to exist
around the chondrocytes. The composition of the extracellular
matrix itself also has an e¡ect on the pH of cartilage; the
large numbers of ¢xed negative charges present on the pro-
teoglycans lead, as a consequence of the Gibbs-Donnan equi-
librium, to an average interstitial pH which is 0.5 pH units
lower than that of the equilibrating synovial £uid [26]. To
date there have been no direct measurements of pH in artic-
ular cartilage but when the additional e¡ect of lactic acid
production is taken into account the di¡erence between the
pH of the synovial £uid and that of the deep regions of the
tissue could be as great as 1 pH unit [26]. It is perhaps not
surprising, therefore, that aggrecan and Lp, which have an
important role in the stability and load bearing properties
of healthy cartilage, can interact maximally with HA over a
wide pH range (between about 6.0 and 8.0; see Fig. 1a,b).
During in£ammation (e.g. in RA) there is likely to be a
signi¢cant reduction in the pH of cartilage, particularly in
pericellular regions, due to increased lactic acid production
by chondrocytes in response to IL-1 [27]. Simkin and Bassett
[28] have shown that lactic acid is the principle determinant of
local acidosis in chronically in£amed synovial joints; normal
synovial £uid has a pH of about 7.3 but the pH can be as low
as 6.8 during in£ammation. IL-1 has a central role in arthritis
promoting the autolytic breakdown of the cartilaginous ma-
trix, while inhibiting its repair (see [17,27]). In cartilage, IL-1
increases the synthesis of some matrix metalloproteinases, cy-
tokines and NO as well as lactate, whereas, production of
collagens, aggrecan and decorin is reduced. In this regard,
the overall reduction in matrix protein and proteoglycan syn-
thesis in cartilage has been shown to be directly related to the
lowering of extracellular pH [29]. IL-1 is also the major stim-
ulator of TSG-6 production by articular chondrocytes in vi-
tro, whilst there is no constitutive expression of this protein by
these cells [14,15].
As discussed above, maximal binding of Link_TSG6 to HA
has a much more restricted range, than is the case for aggre-
can and Lp (between about pH 5.5 and 6.0 - see Fig. 1). In
in£amed cartilage, where TSG-6 is likely to be secreted by
chondrocytes, there is probably a signi¢cantly lower pH
than in healthy tissue. The pH gradients that exist in cartilage
could mediate exquisite regulation of TSG-6 function. It
should be noted that we have not examined the pH depend-
ency of HA (or G1) binding to full-length TSG-6 and it is
possible that other regions of the protein could a¡ect this
property. However, if the pH dependency we have determined
for Link_TSG6 is the same as that of the intact protein, as
seems likely, TSG-6 could interact strongly with both HA and
aggrecan in the vicinity of the chondrocyte but these interac-
tions would be markedly reduced as TSG-6 di¡used towards
the articular surface. The concept that pH gradients may have
an important regulatory role in cartilage has been suggested
previously for the control of proteolytic enzymes [30,31].
The interaction between G1 and Link_TSG6 (at pH 5.8)
can be inhibited by HA (Fig. 4d). This indicates that the
binding surfaces on TSG-6 for these ligands are likely to be
overlapping and that the Link module, at least, is unable to
bind to G1 and HA at the same time. As these studies have
been performed on a recombinant domain of TSG-6 some
caution is necessary when extrapolating these data to func-
tions of the full-length protein. However, these results suggest
that TSG-6 could be involved in the inhibition of aggrecan
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and HA complex formation, regulated by the pH of the chon-
drocyte pericellular environment. It is also possible that TSG-
6 could play a role in the dissociation of cartilage aggregates
by competition of the interaction between aggrecan with HA.
TSG-6 has been shown to form a covalent complex (120
kDa) with components of the serine protease inhibitor, IKI
[32]. This IKI/TSG-6 complex has been found to have signi¢-
cantly increased antiplasmin activity over IKI alone [19]. This
is an interesting ¢nding as plasmin plays an important role in
in£ammation by activating latent metalloproteinases involved
in matrix degradation (see [18]). In this regard, IKI is found in
the synovial £uids of RA and OA patients, but not in con-
trols, covalently associated with HA (see [33]). The IKI/TSG-6
complex has also been detected in the synovial £uids of pa-
tients with various forms of arthritis, but at a signi¢cantly
lower level than uncomplexed TSG-6 [16]. Clearly, the IKI/
TSG-6 complex present in these synovial £uids is likely to
have an anti-in£ammatory role. To our knowledge the pres-
ence of IKI/TSG-6 has not been examined in in£amed carti-
lage. The studies conducted to date on the formation, and
antiplasmin activity, of the IKI/TSG-6 complex have only
been carried out at pH 7.4 [19,32]. Given the dramatic e¡ect
on the interaction of Link_TSG6 with HA and aggrecan it
would be interesting to know if the inhibitor function of IKI/
TSG-6 is also a¡ected by pH. This is possible as the same
region of TSG-6 that binds to HA and G1 may involved in
the increase in the antiplasmin activity of IKI. In this regard
mutations in the Link module a¡ect this activity [19] and these
amino acids are adjacent to the putative HA binding surface
[3]. This raises the intriguing possibility that TSG-6 has a
number of distinct, mutually exclusive, functions that are
regulated by the pH of its particular location.
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